The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.
The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker, evidence from mass spectrometry profiling..pdf
Longuespée, Rémi ; Université des Sciences et Technologies de Lille - USTL > Sciences Naturelles > Laboratoire de Spectrométrie de Masse Biologique Fondamentale et Appliquée
Boyon, Charlotte
Castellier, Céline
Jacquet, Amélie
Desmons, Annie
Kerdraon, Olivier
Vinatier, Denis
Fournier, Isabelle
Day, Robert
Salzet, Michel
Language :
English
Title :
The C-terminal fragment of the immunoproteasome PA28S (Reg alpha) as an early diagnosis and tumor-relapse biomarker: evidence from mass spectrometry profiling.
Publication date :
July 2012
Journal title :
Histochemistry and Cell Biology
ISSN :
0948-6143
eISSN :
1432-119X
Publisher :
Springer Science & Business Media B.V., New York, United States - New York
Bonnel D, Longuespee R, Franck J, Roudbaraki M, Gosset P, Day R, Salzet M, Fournier I (2011) Multivariate analyses for biomarkers hunting and validation through on-tissue bottom-up or in-source decay in MALDI-MSI: application to prostate cancer. Anal Bioanal Chem 401:149-165
Caprioli RM, Farmer TB, Gile J (1997) Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 69:4751-4760
Cornett DS, Mobley JA, Dias EC, Andersson M, Arteaga CL, Sanders ME, Caprioli RM (2006) A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 5:1975-1983 (Pubitemid 44688205)
Djidja MC, Claude E, Snel MF, Francese S, Scriven P, Carolan V, Clench MR (2010) Novel molecular tumour classification using MALDI-mass spectrometry imaging of tissue micro-array. Anal Bioanal Chem 397:587-601
El Ayed M, Bonnel D, Longuespee R, Castelier C, Franck J, Vergara D, Desmons A, Tasiemski A, Kenani A, Vinatier D, Day R, Fournier I, Salzet M (2010) MALDI imaging mass spectrometry in ovarian cancer for tracking, identifying, and validating biomarkers. Med Sci Monit 16:BR233-245
Franck J, Arafah K, Elayed M, Bonnel D, Vergara D, Jacquet A, Vinatier D, Wisztorski M, Day R, Fournier I, Salzet M (2009a) MALDI imaging mass spectrometry: state of the art technology in clinical proteomics. Mol Cell Proteomics 8:2023-2033
Franck J, El Ayed M, Wisztorski M, Salzet M, Fournier I (2009b) On-tissue N-terminal peptide derivatizations for enhancing protein identification in MALDI mass spectrometric imaging strategies. Anal Chem 81:8305-8317
Franck J, Longuespee R, Wisztorski M, Van Remoortere A, Van Zeijl R, Deelder A, Salzet M, McDonnell L, Fournier I (2010) MALDI mass spectrometry imaging of proteins exceeding 30,000 daltons. Med Sci Monit 16:BR293-299
Kehoe S (2008) The management of ovarian carcinoma. Minerva Ginecol 60:155-164 (Pubitemid 351986341)
Longuespée R, Charlotte B, Kerdraon, O, Vinatier D, Fournier I, Day R, Salzet M (2012) MALDI MSI and ovarian cancer biomarkers. Adv Cancer Manag Ed Mohan R:211-236
Khalil I, Brewer MA, Neyarapally T, Runowicz CD (2010) The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer. Gynecol Oncol 116:282-285
Lambaudie E, Collinet P, Vinatier D (2006) Ovarian cancers and CA 125 in 2006. Gynecol Obstet Fertil 34:254-257
Lemaire R, Lucot JP, Collinet P, Vinatier D, Tabet JC, Salzet M, Fournier I (2005) New developments in direct analyses by MALDI mass spectrometry for study ovarian cancer. Mol Cell Proteomics 4:S305-S308
Lemaire R, Tabet JC, Ducoroy P, Hendra JB, Salzet M, Fournier I (2006a) Solid ionic matrixes for direct tissue analysis and MALDI imaging. Anal Chem 78:809-819 (Pubitemid 43230188)
Lemaire R, Wisztorski M, Desmons A, Tabet JC, Day R, Salzet M, Fournier I (2006b) MALDI-MS direct tissue analysis of proteins: improving signal sensitivity using organic treatments. Anal Chem 78:7145-7153 (Pubitemid 44607556)
Lemaire R, Desmons A, Tabet JC, Day R, Salzet M, Fournier I (2007a) Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 6:1295-1305 (Pubitemid 46724026)
Lemaire R, Menguellet SA, Stauber J, Marchaudon V, Lucot JP, Collinet P, Farine MO, Vinatier D, Day R, Ducoroy P, Salzet M, Fournier I (2007b) Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 6:4127-4134 (Pubitemid 350158491)
Lhomme C, Even C, Morice P, Balleyguier C, Petrella M, Gouy S, Uzan C, Duvillard P, Pautier P (2009) First line chemotherapy of advanced epithelial ovarian cancer. Bull Cancer 96:1207-1213
Maines-Bandiera S, Woo MM, Borugian M, Molday LL, Hii T, Gilks B, Leung PC, Molday RS, Auersperg N (2010) Oviductal glycoprotein (OVGP1, MUC9): a differentiation-based mucin present in serum of women with ovarian cancer. Int J Gynecol Cancer 20:16-22
McCombie G, Staab D, Stoeckli M, Knochenmuss R (2005) Spatial and spectral correlations in MALDI mass spectrometry images by clustering and multivariate analysis. Anal Chem 77:6118-6124 (Pubitemid 41436943)
Pevsner PH, Melamed J, Remsen T, Kogos A, Francois F, Kessler P, Stern A, Anand S (2009) Mass spectrometry MALDI imaging of colon cancer biomarkers: a new diagnostic paradigm. Biomark Med 3:55-69
Redeby T, Roeraade J, Emmer A (2004) Simple fabrication of a structured matrix-assisted laser desorption/ionization target coating for increased sensitivity in mass spectrometric analysis of membrane proteins. Rapid Commun Mass Spectrom 18: 1161-1166 (Pubitemid 38691382)
Redeby T, Carr H, Bjork M, Emmer A (2006) A screening procedure for the solubilization of chloroplast membrane proteins from the marine green macroalga Ulva lactuca using RP-HPLC-MALDIMS. Int J Biol Macromol 39:29-36 (Pubitemid 44066534)
Schwamborn K, Krieg RC, Reska M, Jakse G, Knuechel R, Wellmann A (2007) Identifying prostate carcinoma by MALDI-imaging. Int J Mol Med 20:155-159
Schwartz SA, Weil RJ, Johnson MD, Toms SA, Caprioli RM (2004) Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10:981-987 (Pubitemid 38198899)
Seeley EH, Caprioli RM (2008) Imaging mass spectrometry: towards clinical diagnostics. Proteomics Clin Appl 2:1435-1443
Stauber J, Lemaire R, Wisztorski M, Ait-Menguellet S, Lucot JP, Vinatier D, Desmons A, Deschamps M, Proess G, Rudolf I, Salzet M, Fournier I (2006) New developments in MALDI imaging mass spectrometry for pathological proteomic studies: introduction to a novel concept, the specific MALDI imaging. Mol Cell Proteomics 5:S247-S249
Stauber J, Lemaire R, Franck J, Bonnel D, Croix D, Day R, Wisztorski M, Fournier I, Salzet M (2008) MALDI imaging of formalin-fixed paraffin-embedded tissues: application to model animals of Parkinson disease for biomarker hunting. J Proteome Res 7:969-978
Tanner EJ, Black DR, Zivanovic O, Kehoe SM, Dao F, Konner JA, Barakat RR, Lichtman SM, Levine DA (2012) Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer. Gynecol Oncol 124:59-62
Ushijima K (2010) Treatment for recurrent ovarian cancer-at first relapse. J Oncol 497429
van Remoortere A, van Zeijl RJ, van den Oever N, Franck J, Longuespee R, Wisztorski M, Salzet M, Deelder AM, Fournier I (2010) McDonnell LA MALDI imaging and profiling MS of higher mass proteins from tissue. J Am Soc Mass Spectrom 21:1922-1929
